• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植中的心律失常:系统评价和荟萃分析。

Arrhythmias in hematopoietic stem cell transplantation: A systematic review and meta-analysis.

机构信息

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

出版信息

Eur J Haematol. 2019 Dec;103(6):564-572. doi: 10.1111/ejh.13322. Epub 2019 Oct 6.

DOI:10.1111/ejh.13322
PMID:31478231
Abstract

BACKGROUND

There are controversial data regarding the relationship between hematopoietic stem cell transplantation and arrhythmias. This meta-analysis was performed to evaluate the incidence of arrhythmias in patients following hematopoietic stem cell transplantation (HSCT).

METHODS

A literature search was conducted utilizing MEDLINE, EMBASE, and Cochrane Databases from inception through April 2019. Pooled incidence with 95% confidence interval (CI) were calculated using random-effects meta-analysis. The protocol for this meta-analysis is registered with PROSPERO (International Prospective Register of Systematic Reviews; no. CRD42019131833).

RESULTS

Thirteen studies consisting of 10,587 patients undergoing HSCT were enrolled in this systematic review. Overall, the pooled estimated incidence of all types of arrhythmias following HSCT was 7.2% (95% CI: 4.9%-10.5%). With respect to the most common type of arrhythmia, the pooled estimated incidence of atrial fibrillation/atrial flutter (AF/AFL) within 30 days following HSCT was 4.2% (95% CI: 1.7%-9.6%). Egger's regression test demonstrated no significant publication bias in this meta-analysis of post-HSCT arrhythmia incidence.

CONCLUSION

The overall estimated incidence of arrhythmias following HSCT was 7.2%. Future large scale studies are needed to further elucidate the significance and clinical impact of arrhythmias in post-HSCT patients.

摘要

背景

关于造血干细胞移植与心律失常之间的关系,目前存在一些争议数据。本荟萃分析旨在评估造血干细胞移植(HSCT)后患者心律失常的发生率。

方法

通过检索 MEDLINE、EMBASE 和 Cochrane 数据库,从建库至 2019 年 4 月,对所有相关研究进行文献检索。使用随机效应荟萃分析计算合并发生率及其 95%置信区间(CI)。本荟萃分析的方案已在 PROSPERO(国际前瞻性系统评价注册库;注册号:CRD42019131833)上注册。

结果

本系统评价共纳入 13 项研究,共纳入 10587 例接受 HSCT 的患者。总体而言,HSCT 后所有类型心律失常的合并估计发生率为 7.2%(95%CI:4.9%-10.5%)。关于最常见的心律失常类型,HSCT 后 30 天内心房颤动/心房扑动(AF/AFL)的合并估计发生率为 4.2%(95%CI:1.7%-9.6%)。Egger 回归检验显示,本荟萃分析中 HSCT 后心律失常发生率无明显发表偏倚。

结论

HSCT 后心律失常的总体估计发生率为 7.2%。需要进一步开展大规模研究以阐明 HSCT 后患者心律失常的意义和临床影响。

相似文献

1
Arrhythmias in hematopoietic stem cell transplantation: A systematic review and meta-analysis.造血干细胞移植中的心律失常:系统评价和荟萃分析。
Eur J Haematol. 2019 Dec;103(6):564-572. doi: 10.1111/ejh.13322. Epub 2019 Oct 6.
2
Echocardiographic predictors of new-onset atrial arrhythmias in patients undergoing hematopoietic stem cell transplantation.超声心动图预测造血干细胞移植患者新发房性心律失常的发生。
Int J Cardiol. 2021 Sep 15;339:225-231. doi: 10.1016/j.ijcard.2021.06.038. Epub 2021 Jun 23.
3
Incidence, risk factors and prognosis of postoperative atrial arrhythmias after lung transplantation: a systematic review and meta-analysis.肺移植术后房性心律失常的发病率、危险因素及预后:一项系统评价和荟萃分析
Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):790-799. doi: 10.1093/icvts/ivw208. Epub 2016 Jun 29.
4
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).影响自体造血干细胞移植(auto-HSCT)后心房颤动和心房扑动(AF/AFL)发展的因素。
Bone Marrow Transplant. 2013 Jul;48(7):963-5. doi: 10.1038/bmt.2012.253. Epub 2012 Dec 10.
5
Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.造血干细胞移植后静脉血栓栓塞——一项系统评价与荟萃分析
Ann Hematol. 2016 Sep;95(9):1457-64. doi: 10.1007/s00277-016-2673-3. Epub 2016 Apr 22.
6
Association Between Depression Before Hematopoietic Stem Cell Transplantation and Posttransplant Survival: A Systematic Review and Meta-analysis.移植前抑郁症与造血干细胞移植后生存的关系:系统评价和荟萃分析。
J Acad Consult Liaison Psychiatry. 2023 Mar-Apr;64(2):166-176. doi: 10.1016/j.jaclp.2022.12.006. Epub 2022 Dec 17.
7
Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation.关于更新一项针对接受造血干细胞移植患者预防性使用静脉注射免疫球蛋白的随机对照试验系统评价的方案。
BMJ Open. 2015 Aug 21;5(8):e008316. doi: 10.1136/bmjopen-2015-008316.
8
Vitamin D deficiency is not associated with graft versus host disease after hematopoietic stem cell transplantation: A meta-analysis.维生素 D 缺乏与造血干细胞移植后移植物抗宿主病无关:一项荟萃分析。
J Evid Based Med. 2020 Aug;13(3):183-191. doi: 10.1111/jebm.12383. Epub 2020 May 5.
9
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation.自体外周血造血干细胞移植期间的室上性心律失常发生率。
Biol Blood Marrow Transplant. 2013 Aug;19(8):1233-7. doi: 10.1016/j.bbmt.2013.05.019. Epub 2013 Jun 6.
10
Late atrial arrhythmias after lung transplantation: a meta-analysis.肺移植后晚期房性心律失常:荟萃分析。
J Cardiovasc Med (Hagerstown). 2020 Aug;21(8):577-582. doi: 10.2459/JCM.0000000000001012.

引用本文的文献

1
Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: State-of-the-Art Review.成人造血干细胞移植后的心血管疾病:最新综述
JACC CardioOncol. 2024 Aug 20;6(4):475-495. doi: 10.1016/j.jaccao.2024.06.004. eCollection 2024 Aug.
2
Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors.造血干细胞移植后的心血管事件:发生率及危险因素
JACC CardioOncol. 2023 Sep 19;5(6):821-832. doi: 10.1016/j.jaccao.2023.07.007. eCollection 2023 Dec.
3
Assessing and Preparing Patients for Hematopoietic Stem Cell Transplant in Canada: An Environmental Scan of Psychosocial Care.
加拿大造血干细胞移植患者的评估和准备:心理社会护理的环境扫描。
Curr Oncol. 2023 Sep 15;30(9):8477-8487. doi: 10.3390/curroncol30090617.
4
Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation.心房颤动与骨髓移植患者结局的相关性。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad129.
5
Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography.心脏肿瘤学中的人工智能机遇:聚焦心电图的概述
Am Heart J Plus. 2022 Mar;15. doi: 10.1016/j.ahjo.2022.100129. Epub 2022 Apr 1.
6
Cardiac complications associated with hematopoietic stem-cell transplantation.造血干细胞移植相关的心脏并发症。
Bone Marrow Transplant. 2021 Nov;56(11):2637-2643. doi: 10.1038/s41409-021-01427-2. Epub 2021 Aug 11.
7
Interactions between cardiology and oncology drugs in precision cardio-oncology.精准心脏肿瘤学中心血管药物与肿瘤药物的相互作用。
Clin Sci (Lond). 2021 Jun 11;135(11):1333-1351. doi: 10.1042/CS20200309.
8
Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.异体造血细胞移植患者的心房颤动。
J Clin Oncol. 2021 Mar 10;39(8):902-910. doi: 10.1200/JCO.20.02401. Epub 2021 Jan 8.
9
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation.造血干细胞移植患者中的儿童和成人的心血管疾病及其管理。
J Thromb Thrombolysis. 2021 May;51(4):854-869. doi: 10.1007/s11239-020-02344-9. Epub 2020 Nov 24.